Manuela Matesan
University of Washington, USA
Biography
Manuela Matesan involved in imaging interpretations in particular PET scans for oncologic patients. I was previously involved in several oncologic treatment projects including radioimmunotherapy using 90Yttrium labeled anti-CD20 (Ibritumomab tiuxetan) and radiolabeled anti-CD 45 antibodies in patients with hematologic malignancies. Results of these studies have been materialized in published manuscripts and conferences presentations. Also, I am currently involved in projects regarding side effects of lymphoma treatments.
Abstract
Abstract : PET imaging in lymphoma: An update on clinical trails guidelines and clinical practice indications